Heart failure and the soluble prorenin receptor (sPRR): results from the CIBIS-ELD trial

被引：0
|
作者：
Duengen, H-D [1 ]
Trippel, T-D [1 ]
Tahirovic, E. [1 ]
Mueller, D. N. [2 ,3 ]
Wilck, N. [2 ,3 ]
Wachter, R. [4 ]
Heidecke, H. [5 ]
Busjahn, A. [6 ]
Pieske, B. [7 ]
Dechend, R. [2 ,3 ]
机构：
[1] Charite Campus Virchow Klinikum CVK, Berlin, Germany
[2] Charite Campus Buch, Charite Campus Berlin Buch CBB, Expt Clin Res Ctr, Berlin, Germany
[3] Max Delbrueck Ctr, Berlin, Germany
[4] Univ Med Ctr Gottingen UMG, Dept Cardiol, Gottingen, Germany
[5] CellTrend, Lueckenwalde, Germany
[6] Hlth Twist, Berlin, Germany
[7] Med Univ Graz, Dept Cardiol, Graz, Austria
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3653
引用
收藏
页码：667 / 668
页数：2
相关论文
共 50 条
  • [41] Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study
    Milica Dekleva
    Hans-Dirk Düngen
    Götz Gelbrich
    Simone Incrot
    Jelena Suzic Lazic
    Milena Pavlovic Kleut
    Elvis Tahirovic
    Finn Waagstein
    Aging Clinical and Experimental Research, 2012, 24 : 675 - 681
  • [42] Use of MR-proANP and NT-proBNP in the timing of beta blocker up-titration in elderly patients with stable chronic heart failure: Data from the CIBIS-ELD study
    Sekularac, N.
    Von Haehling, S.
    Loncar, G.
    Tahirovic, E.
    Inkrot, S.
    Apostolovic, S.
    Putnikovic, B.
    Waagstein, F.
    Gelbrich, G.
    Duengen, H. D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 162 - 162
  • [43] Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study
    Dekleva, Milica
    Duengen, Hans-Dirk
    Gelbrich, Goetz
    Incrot, Simone
    Lazic, Jelena Suzic
    Kleut, Milena Pavlovic
    Tahirovic, Elvis
    Waagstein, Finn
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 24 (06) : 675 - 681
  • [44] Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.
    Apostolovic, S.
    Stanojevic, D. Dragana
    Salinger-Martinovic, S.
    Jankovic-Tomasevic, R.
    Djordjevic-Radojkovic, D.
    Kostic, T.
    Mitic, V.
    Atanaskovic, V.
    Dakic, S.
    Dungen, H. D.
    Tahirovic, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 287 - 288
  • [45] Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study
    Milica Dekleva
    Hans-Dirk Düngen
    Götz Gelbrich
    Simone Incrot
    Jelena Suzic Lazic
    Milena Pavlovic Kleut
    Elvis Tahirovic
    Finn Waagstein
    Aging Clinical and Experimental Research, 2012, 24 (6) : 675 - 681
  • [46] Independent country and gender differences in quality of life after beta-blocker up-titration in German and Serbian patients: analysis from the CIBIS-ELD trial
    Duengen, H. D.
    Tahirovic, E.
    Zelenak, C.
    Trippel, T.
    Fritschka, M.
    Celic, V.
    Apostolovic, S.
    Pieske, B.
    Chavanon, M. L.
    Herrmann-Lingen, C.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2015, 14 : S22 - S22
  • [47] SURVIVAL AND PROGNOSTIC FACTORS IN HEART-FAILURE DURING THE CIBIS TRIAL
    LECHAT, P
    BOISSEL, JP
    NEMOZ, C
    JAILLON, P
    CIRCULATION, 1994, 90 (04) : 380 - 380
  • [48] High plasma soluble prorenin receptor (sPRR) levels correlate with systolic blood pressure in aged male but not in female mice
    Visniauskas, Bruna
    Wong, Christopher T. U.
    Crabtree, Stephanie L.
    Hong, Jennifer
    Reverte, Virginia
    Rosales, Carla B.
    Mejia-Gomez, Hernan
    Mostany, Ricardo
    Prieto, Minolfa C.
    FASEB JOURNAL, 2019, 33
  • [49] The Soluble Form of the Prorenin Receptor (sPRR) is Augmented in Distal Nephron Segments and Urine of Chronic Angiotensin II-Dependent Hypertensive Rats
    Prieto, Minolfa C.
    Gonzalez, Alexis A.
    Lara, Lucienne S.
    HYPERTENSION, 2010, 56 (05) : E132 - E132
  • [50] Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure
    Erdmann, E
    Lechat, P
    Verkenne, P
    Wiemann, H
    EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (04) : 469 - 479
12345